Arkolith/Insider Trading/APYX/Form 4

Goodwin Charles D. II

Chief Executive Officer, DirectorApyx Medical Corp (APYX) · full profile →Form 4 · filed Nov 15, 2023
Net Buying
Open-Market Buys
$79K
Open-Market Sells
$0
Net Open-Market Flow
$79K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 14, 2023Buy(P)50K$1.57$79K90K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-041501) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML